| scholarly article | Q13442814 |
| P50 | author | John D. Roberts | Q97686184 |
| P2093 | author name string | Lesley Devine | |
| Amanda M Brandow | |||
| Michelle DeVeaux | |||
| Susanna A Curtis | |||
| Daniel Zeltermam | |||
| P2860 | cites work | The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report | Q47556755 |
| Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D. | Q50138176 | ||
| Sickle cell disease: a natural model of acute and chronic pain. | Q55053106 | ||
| Cannabis-based medicines for chronic neuropathic pain in adults | Q56815074 | ||
| The number of people with sickle-cell disease in the United States: national and state estimates | Q82320507 | ||
| Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees | Q88250253 | ||
| Marijuana Use in Adults Living with Sickle Cell Disease | Q90263166 | ||
| Prevalence and correlates of non-medical only compared to self-defined medical and non-medical cannabis use, Canada, 2015 | Q90313391 | ||
| Association of Cannabinoid Administration With Experimental Pain in Healthy Adults: A Systematic Review and Meta-analysis | Q93030201 | ||
| Adult sickle cell quality-of-life measurement information system (ASCQ-Me): conceptual model based on review of the literature and formative research | Q27318644 | ||
| Cannabinoids for Medical Use | Q29391539 | ||
| Marginal structural models and causal inference in epidemiology | Q29619287 | ||
| Construct validity of the Patient-Reported Outcomes Measurement Information System gastrointestinal symptom scales in systemic sclerosis | Q33461240 | ||
| Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠. | Q33755816 | ||
| Patient reports of health outcome for adults living with sickle cell disease: development and testing of the ASCQ-Me item banks | Q34570608 | ||
| Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010 | Q34664106 | ||
| Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS®): depression, anxiety, and anger | Q35156948 | ||
| Neuropathic pain in patients with sickle cell disease | Q35170917 | ||
| Elevated Steady State WBC and Platelet Counts Are Associated with Frequent Emergency Room Use in Adults with Sickle Cell Anemia | Q35738945 | ||
| The prevalence of marijuana smoking in young adults with sickle cell disease: a longitudinal study. | Q36716868 | ||
| A PROMIS Measure of Neuropathic Pain Quality | Q37212754 | ||
| Stress-related factors in cannabis use and misuse: implications for prevention and treatment | Q37228852 | ||
| Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever. | Q38750804 | ||
| Cannabis use in sickle cell disease: a questionnaire study | Q39361744 | ||
| Cannabis use for chronic non-cancer pain: results of a prospective survey | Q39397282 | ||
| National Estimates of Marijuana Use and Related Indicators - National Survey on Drug Use and Health, United States, 2002-2014. | Q39432315 | ||
| The Use of Cannabis by Patients with Sickle Cell Disease Increased the Frequency of Hospitalization due to Vaso-Occlusive Crises | Q42714638 | ||
| The use of cannabis in response to the opioid crisis: A review of the literature | Q43075852 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 255-262 | |
| P577 | publication date | 2020-09-02 | |
| P1433 | published in | Cannabis and cannabinoid research | Q27727510 |
| P1476 | title | Daily Cannabis Users with Sickle Cell Disease Show Fewer Admissions than Others with Similar Pain Complaints | |
| P478 | volume | 5 |
Search more.